MARATTO

article · International Journal of Pharmaceutics

Clarithromycin-tailored cubosome: A sustained release oral nano platform for evaluating antibacterial, anti-biofilm, anti-inflammatory, anti-liver cancer, biocompatibility, ex-vivo and in-vivo studies

20241 citationZagazig University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Antimicrobial Peptides and Activities
  • Lipid Membrane Structure and Behavior
  • Advanced biosensing and bioanalysis techniques

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.ijpharm.2024.124865

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.